Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 08, 2024.
All times in Eastern Daylight Time.
-
KBRA Releases Research – FHFA Closed-End Seconds: Effect on PLS?NEW YORK--(BUSINESS WIRE)--The Federal Housing Finance Agency (FHFA) on April 16 issued a notice and a request for comment related to a proposal whereby Freddie Mac could purchase single-family clo... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 07.05.2024 FGBL.LN IE00BYTH6121 66,146.00 USD ... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 07.05.2024 FKUD IE00BD9N0445 111,095.00 GBP... more »
-
Trane Technologies and the U.S. Department of Energy Partner to Advance Building Decarbonization in New Heat Pump Technology ChallengeSWORDS, Ireland--(BUSINESS WIRE)--Trane Technologies (NYSE: TT), a global climate innovator, today announced its participation in the U.S. Department of Energy’s (DOE) Commercial Building Heat Pump... more »
-
ITT Announces Participation at 17th Annual Wolfe Research Global Transportation & Industrials Conference on May 22STAMFORD, Conn.--(BUSINESS WIRE)--ITT Inc. today announced its participation at the 17th Annual Wolfe Research Global Transportation & Industrials Conference on May 22 in New York. more »
-
American Clinical Research Services Announces Strategic Acquisition of ElixiaRALEIGH, N.C.--(BUSINESS WIRE)--American Clinical Research Services Announces Strategic Acquisition of Elixia more »
-
Lubrizol Showcases LIPOFER™ Microencapsulation Technology, Introduces New EU Food-Grade Approval for Carbopol® Polymers at Vitafoods Europe 2024CLEVELAND--(BUSINESS WIRE)--The Lubrizol Corporation will showcase its LIPOFER™ microcapsules that deliver iron with optimum performance at Vitafoods Europe. more »
-
Wolverine Worldwide Appoints Taryn Miller as Chief Financial OfficerROCKFORD, Mich.--(BUSINESS WIRE)--Wolverine World Wide, Inc. (NYSE: WWW) today announced that it has appointed Taryn Miller as the Company’s Chief Financial Officer, effective May 9, 2024. Ms. Mill... more »
-
HF Sinclair Corporation Reports 2024 First Quarter Results and Announces Regular Cash DividendDALLAS--(BUSINESS WIRE)--HF Sinclair Corporation (NYSE: DINO) (“HF Sinclair” or the “Company”) today reported first quarter net income attributable to HF Sinclair stockholders of $314.7 million, or... more »
-
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaPARSIPPANY, N.J. & TEL AVIV & PARIS--(BUSINESS WIRE)--Regulatory News: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: ... more »
-
Eaton to supply innovative ELocker differential system to leading electrified vehicle manufacturerSOUTHFIELD, Mich.--(BUSINESS WIRE)--Eaton has been selected by a leading electrified vehicles manufacturer to supply its ELocker® differential system for a plug-in electric hybrid SUV. more »
-
PARSIPPANY, N.J. & TEL AVIV & PARIS--(BUSINESS WIRE)--ACCESS HERE THE COMPLETE PRESS RELEASE Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and... more »
-
Teva et Medincell annoncent des résultats d'efficacité positifs pour l’essai de phase 3 SOLARIS de TEV-‘749 (olanzapine / mdc-TJK), injection sous-cutanée à action prolongée mensuelle pour les adultes atteints de schizophréniePARSIPPANY, N.J. & TEL AVIV & PARIS--(BUSINESS WIRE)--Regulatory News: Teva Pharmaceuticals, filiale américaine de Teva Pharmaceutical Industries Ltd. (NYSE et TASE : TEVA), et Medincell (Euronext ... more »
-
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaPARSIPPANY, N.J. & TEL AVIV, Israel & PARIS--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), t... more »